Cancer Care Ontario transitioning to fecal immunochemical test

June 03, 2019

Message on behalf of Cancer Care Ontario.
Cancer Care Ontario through its ColonCancerCheck (CCC) screening program is transitioning to the fecal immunochemical test (FIT) as the recommended screening test for people at average risk of developing colorectal cancer. The guaiac fecal occult blood test (gFOBT) will no longer be used in the CCC program.
The FIT will be available through the CCC program on June 24, 2019. With the transition to FIT, please direct participants without a primary care provider to contact Telehealth Ontario to obtain a FIT kit.

The PIN – 93899960 – for Ontario Drug Benefit claims submission of a gFOBT kit distributed from a community pharmacy and billed through the Health Network System will be discontinued on June 23, 2019 at midnight.

Once FIT becomes available, laboratory providers will arrange the removal of unused CCC gFOBT kits from pharmacies. Current CCC gFOBT requisitions used by pharmacies will be discontinued after the FIT becomes available. Patients who do not have a primary care provider can continue to contact Telehealth Ontario to obtain a FIT kit.

Telehealth can be reached: Toll-free: 1-866-797-0000 or Toll-free TTY: 1-866-797-0007.

For more information on the implementation of the FIT including eligibility criteria, please visit the FIT Resource Hub at

Additional Information:

For pharmacies: Please call ODB Pharmacy Help Desk at: 1-800-668-6641

For all other Health Care Providers and the Public: Please contact CCO Cancer Screening Program at or 1.866.662.9233 Monday to Friday between 8:30 a.m. and 5:00 p.m.